MedWatch

Wegovy update on Novo Nordisk's capital markets day agenda

According to the program for Novo Nordisk’s capital markets day, one key highlight concerns a Wegovy update. The meeting takes place today, Thursday.

Photo: Stine Tidsvilde

Novo Nordisk’s capital markets day transpires on Thursday, and the pharmaceutical firm has aired some key highlights ahead of the meeting, as announced in a stock notification.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs